Material Agreements

Serve Robotics Inc. /DE/ entered into Underwriting Agreement with Aegis Capital Corp. valued at 10,000,000 shares of the Company’s common stock, par value $0.0001 per share, at a public offering p (effective 2024-04-17).

“On April 17, 2024 (the “Effective Date”), Serve Robotics Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Aegis Capital Corp. (“Aegis”) in connection with the public offering of 10,000,000 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a public offering price of $4.00 per share”

ContextLogic Inc. terminated Revolving Credit Facility with JPMorgan Chase Bank, N.A. valued at up to $280 million (effective 2024-04-19).

“On April 19, 2024, at the closing of the Asset Sale, the Company terminated its Revolving Credit Agreement, dated as of November 20, 2020, by and among the Company, as the Borrower, the Lenders party thereto, the Issuing Banks party thereto, and JPMorgan Chase Bank, N.A., as the Administrative Agent (the “ Revolving Credit Facility ”), as well as the related security agreements.”

Tarsus Pharmaceuticals, Inc. entered into Loan Agreement with funds managed by Pharmakon Advisors LP, BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership, as lenders, and BioPharma Credit PLC, as collateral agent valued at initial term loan in the principal amount of $75 million (effective 2024-04-19).

“On April 19, 2024, Tarsus Pharmaceuticals, Inc., a Delaware corporation (the “Company”) entered into an agreement with funds managed by Pharmakon Advisors LP, BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership, as lenders, and BioPharma Credit PLC, as collateral agent for the lenders, and the guarantors party to such agreement (the “Loan Agreement”). The Loan Agreement provides for an initial term loan in the principal amount of $75 million”

Renalytix plc entered into Purchase Agreement with DB Capital Partners Healthcare, L.P. (effective 2024-04-05).

“on April 5, 2024, Renalytix plc (the “ Company ”) entered into a securities purchase agreement (the “ Purchase Agreement ”) with DB Capital Partners Healthcare, L.P. (the “ Purchaser ”)”

Vertex, Inc. amended Fourth Amendment to Credit Agreement with the guarantors party thereto, PNC Bank, National Association, as administrative agent, and the lenders party thereto (effective 2024-04-19).

“On April 19, 2024, Vertex, Inc. (the “Company”), the guarantors party thereto, PNC Bank, National Association, as administrative agent, and the lenders party thereto entered into the Fourth Amendment to Credit Agreement (the “Fourth Amendment”), which amended the Credit Agreement by and among the Company, the guarantors party thereto, PNC Bank, National Association, as administrative agent, and the lenders party thereto, dated as of March 31, 2020 (as previously amended, the “Credit Agreement”), providing for, among other things, amendment of the definition of “Approved Convertible Debt” in Section 1.1 of the Credit Agreement by deleting the phrase “Two Hundred Million Dollars ($200,000,000)” and inserting in lieu thereof the phrase “Three Hundred Million Dollars ($300,000,000).””

NexPoint Real Estate Finance, Inc. entered into NREF Note with NexPoint Diversified Real Estate Trust Operating Partnership, L.P. valued at $6.5 million (effective 2024-04-19).

“borrowed $6.5 million from NexPoint Diversified Real Estate Trust Operating Partnership, L.P. (“NXDT OP”), the operating partnership of NexPoint Diversified Real Estate Trust, an entity that is advised by an affiliate of the manager of NREF. In connection with the loan, OP IV issued a $6.5 million note (the “NREF Note”) to NXDT OP on April 19, 2024.”

Morgan Stanley Direct Lending Fund amended Fourth Amendment with the lenders and issuing banks from time to time parties thereto, Truist Bank, as Administrative Agent, Truist Securities, Inc., as Joint Lead Arranger and Sole Book Runner, and ING Capital LLC, MUFG Bank, Ltd., and Sumitomo Mitsui Banking Corporation, as additional Joint Lead Arrangers valued at $1,300,000,000 (effective 2024-04-19).

“On April 19, 2024, Morgan Stanley Direct Lending Fund (the “Company”), a Delaware corporation, entered into an amendment (the “Fourth Amendment”) to that certain Senior Secured Revolving Credit Agreement”

ATIF Holdings Ltd entered into Purchase Agreements with one U.S. accredited investor and one non-U.S. investor valued at gross proceeds in the amount of $1,000,002.38 (effective 2024-04-18).

“On April 18, 2024, ATIF Holdings Limited (the “Company”) entered into two securities purchase agreements (the “Purchase Agreements”) in a private placement (the “Private Placement”) of the Company’s newly issued ordinary shares”

Datavault AI Inc. entered into Placement Agency Agreement with Maxim Group LLC valued at Placement agent on reasonable best efforts basis; fee of 8.0% of gross proceeds; expense reimburseme (effective 2024-04-19).

“on April 19, 2024, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC (the “Placement Agent”), pursuant to which the Placement Agent agreed to act as placement agent on a “reasonable best efforts” basis in connection with the Offerings.”

Datavault AI Inc. entered into Securities Purchase Agreement with certain purchasers valued at Registered direct offering of 361,904 shares at $5.25 per share and concurrent private placement of (effective 2024-04-19).

“On April 23, 2024, the Company closed (the “Closing”) an offering with certain purchasers signatory to that certain securities purchase agreement dated April 19, 2024 (the “Purchase Agreement”).”

NutriBand Inc. entered into Subscription Agreement with European investors valued at $8,400,000 (effective 2024-04-19).

“On April 19, 2024, the Company completed an $8,400,000 equity financing with European investors (the “Offering”) of 2,100,000 units (“Units”), at a price of $4.00 per Unit, each Unit consisting of one share of common stock (“Shares”) and a Warrant to purchase two Shares of common stock (the “Warrants”).”

AMERICAN REBEL HOLDINGS INC entered into Revenue Interest Purchase Agreement with an individual accredited investor valued at $500,000 (effective 2024-04-19).

“On April 19, 2024, the Registrant entered into a Revenue Interest Purchase Agreement (the “ Revenue Interest Purchase Agreement ”) with an individual accredited investor, pursuant to which the investor purchased a revenue interest from the Registrant for $500,000.”

Boxlight Corp amended Sixth Amendment with Whitehawk Capital Partners LP, Whitehawk Finance LLC valued at $2,000,000 additional working capital bridge loan, $3,000,000 additional working capital bridge loan (effective 2024-04-19).

“On April 19, 2024, Boxlight Corporation, a Nevada corporation (the “Company”), entered into a sixth amendment (the “Sixth Amendment”) to the credit agreement (the “Credit Agreement”) with Whitehawk Capital Partners LP, as collateral agent (the “Collateral Agent”), and Whitehawk Finance LLC (the “Lender”).”

Nixxy, Inc. amended Amendment to Technology License and Commercialization Agreement with GoLogiq, Inc. valued at added Section 3.3 for technical assistance; amended Section 5.1 to lower royalty from 8% to 5%, gran (effective 2024-03-28).

“On March 28, 2024 (the "Effective Date"), the Company and GOLQ entered into an Amendment to Technology License and Commercialization Agreement (the "Amendment").”

Nixxy, Inc. entered into Technology License and Commercialization Agreement with GoLogiq, Inc. valued at worldwide, exclusive license; duration 10 years with automatic two-year renewals (effective 2024-02-23).

“On February 23, 2024, the Company entered into a certain Technology License and Commercialization Agreement (the "GOLQ Licensing Agreement") with GoLogiq, Inc. ("GOLQ") whereby GOLQ grants the Company a worldwide, exclusive license (the "GOLQ License") to the Company to develop its fintech technology (the "GOLQ Technology") and sell products derived thereof, including its Createapp, Paylogiq, Gologiq, and Radix AI technology and products (the "Licensed Products"), for a term of 10 years, with automatic two (2) year renewals as further described therein (the "Term").”

Spirit AeroSystems Holdings, Inc. entered into Memorandum of Agreement with The Boeing Company valued at $425,000,000 (effective 2024-04-18).

“On April 18, 2024, Spirit AeroSystems, Inc. (“Spirit”), a wholly owned subsidiary of Spirit AeroSystems Holdings, Inc. (“Spirit Holdings”), and The Boeing Company (“Boeing”) entered into a Memorandum of Agreement (the “MOA”).”

NEXPOINT DIVERSIFIED REAL ESTATE TRUST entered into NREF Note with NREF OP IV, L.P. valued at $6.5 million (effective 2024-04-19).

“On April 19, 2024, NexPoint Diversified Real Estate Trust Operating Partnership, L.P. (“NXDT OP”), the operating partnership of NexPoint Diversified Real Estate Trust (“NXDT”), loaned $6.5 million to NREF OP IV, L.P. (“NREF OP IV”), a subsidiary of NexPoint Real Estate Finance, Inc. (“NREF”), an entity that is managed by an affiliate of the adviser of NXDT. In connection with the loan, NREF OP IV issued a promissory note in the principal amount of $6.5 million to NXDT OP (the “NREF Note”).”

Fidelity National Financial, Inc. amended Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. (effective 2024-04-22).

“On April 22, 2024, Fidelity National Financial, Inc. (the “Company”) and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”), entered into a supplemental indenture (the “Supplemental Indenture”) to the indenture, dated as of December 8, 2005 (the “Indenture”), governing the Company’s 4.500% Senior Notes due 2028 (the “2028 Notes”), 3.400% Senior Notes due 2030 (the “2030 Notes”), 2.450% Senior Notes due 2031 (the “2031 Notes”) and 3.200% Senior Notes due 2051 (the “2051 Notes” and, collectively, the “Notes”; and each a “series of Notes”).”

COHEN & STEERS, INC. terminated ATM Equity Offering Sales Agreement with BofA Securities, Inc. valued at up to $100,000,000 (effective 2024-04-22).

“On April 22, 2024, the Company delivered written notice to BofA Securities that it was terminating the Sales Agreement, effective April 22, 2024, pursuant to Section 9(a) of the Sales Agreement.”

Vivani Medical, Inc. entered into Open Market Sale Agreement with Jefferies LLC valued at up to $75.0 million (effective 2024-04-22).

“On April 22, 2024, Vivani Medical, Inc. (the “Company”) entered into an Open Market Sale Agreement SM (the “Agreement”) with Jefferies LLC (“Jefferies”), under which the Company may offer and sell, from time to time at its sole discretion, shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $75.0 million through Jefferies as its sales agent.”

Cencora, Inc. amended Omnibus Amendment with MUFG Bank, Ltd., as administrator, and the purchaser agents and purchasers party thereto (effective 2024-04-17).

“On April 17, 2024, Cencora, Inc. (the “ Company ”) and certain of its subsidiaries entered into an Omnibus Amendment (the “ Omnibus Amendment ”) with MUFG Bank, Ltd., as administrator, and the purchaser agents and purchasers party thereto”

Seagate Technology Holdings plc entered into Asset Purchase Agreement with Avago Technologies International Sales Pte. Limited valued at $600,000,000 (effective 2024-04-23).

“On April 23, 2024, Seagate Technology Holdings public limited company (the “ Company ” or “ Seagate ”) and Seagate Technology LLC, a Delaware limited liability company, Seagate Technology HDD (India) Private Limited, a private company incorporated under the laws of India, and Seagate Singapore International Headquarters Pte. Ltd., a private company incorporated under the laws of Singapore, each a subsidiary of the Company (such subsidiaries, the “ Seagate Sellers ”), entered into an Asset Purchase Agreement (the “ APA ”) with Avago Technologies International Sales Pte. Limited, a private company incorporated under the laws of Singapore (“ Purchaser ”) and a subsidiary of Broadcom Inc.”

RxSight, Inc. amended 100 Columbia Amendment with Accuride International Inc. valued at $64,843 per month (effective 2024-04-18).

“On April 18, 2024, the Company entered into a Fifth Amendment to that certain Commercial Lease Agreement, dated August 31, 2015, as amended November 23, 2015, December 22, 2015, January 18, 2016, and November 12, 2016, with Accuride International Inc., for the property located at 100 Columbia in Aliso Viejo, California (the “100 Columbia Amendment”).”

RxSight, Inc. amended 5 Columbia Amendment with Clifford D. Downs valued at $30,701 per month (effective 2024-04-18).

“On April 18, 2024, the Company entered into Lease Amendment #2 to that certain Lease Agreement dated January 10, 2018, as amended on April 5, 2022, with Clifford D. Downs, for the property located at 5 Columbia in Aliso Viejo, California (the “5 Columbia Amendment”).”

RxSight, Inc. entered into 125 Columbia Lease with BML Management, LLC valued at $41,579 per month (effective 2024-04-18).

“On April 18, 2024, the Company entered into a Standard Industrial/Commercial Single-Tenant Lease – Net (the “125 Columbia Lease”) with BML Management, LLC, for an approximately 26,825 square foot industrial and research and development facility in Aliso Viejo, California.”

United Airlines Holdings, Inc. entered into Amendment No. 3 to Tax Benefits Preservation Plan with Computershare Trust Company, N.A. (effective 2024-04-22).

“On April 20, 2024, the board of directors of United Airlines Holdings, Inc. (the “Company”) unanimously approved, and on April 22, 2024, the Company entered into, that certain Amendment No. 3 to Tax Benefits Preservation Plan (“Amendment No. 3”), which amends the Tax Benefits Preservation Plan, dated as of December 4, 2020 and as amended as of January 21, 2021 and December 4, 2023 (the “Plan”), by and between the Company and Computershare Trust Company, N.A., as rights agent (the “Rights Agent”).”

TREDEGAR CORP amended Fourth Amendment with JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto (effective 2024-04-16).

“On April 16, 2024, Tredegar Corporation (the “ Company ”), as borrower, and certain of the Company’s material domestic subsidiaries, as guarantors (the “ Guarantors ”), entered into Amendment No. 4 (the “ Fourth Amendment ”) to the Second Amended and Restated Credit Agreement dated June 29, 2022 (as previously amended, the “ Amended Credit Agreement ”), among JPMorgan Chase Bank, N.A., as administrative agent (the “ Agent ”), Citizens Bank, N.A. and PNC Bank, National Association, as co-syndication agents, and Bank of America, N.A., U.S. Bank National Association and Wells Fargo Bank, National Association, as co-documentation agents, and the other lenders party thereto (collectively, the “ Lenders ”).”

SOLIGENIX, INC. entered into Placement Agency Agreement with A.G.P./Alliance Global Partners valued at cash fee of six and one-half percent (6.5%) of the gross proceeds of the Offering (effective 2024-04-17).

“A.G.P./Alliance Global Partners acted as the sole placement agent (the “Placement Agent”) on a “reasonable best efforts” basis in connection with the Offering pursuant to a Placement Agency Agreement, dated April 17, 2024, by and between the Company and the Placement Agent (the “Placement Agency Agreement”).”

SOLIGENIX, INC. entered into Securities Purchase Agreement with certain investors valued at aggregate gross proceeds from the Offering are approximately $4.75 million (effective 2024-04-17).

“On April 17, 2024, Soligenix, Inc., a Delaware corporation (the “Company”) entered into a Securities Purchase Agreement with certain investors (the “Investors”), pursuant to which the Company agreed to issue and sell to the Investors in a public offering (the “Offering”) (i) 3,275,000 shares of the Company’s common stock, (ii) pre-funded warrants to purchase 8,600,000 shares of the Company’s common stock and (iii) common warrants to purchase 11,875,000 shares of the Company’s common stock.”

Nature's Miracle Holding Inc. entered into Debt Purchase Term Sheet with CP Acquisitions LLC and GIC Acquisition, LLC valued at Nature's Miracle will purchase approximately $13.1 million of Agrify's Senior Note and the Junior No (effective 2024-04-17).

“In connection with the closing of the Proposed Merger, Nature’s Miracle executed a separate term sheet related to the current debt of Agrify held by two entities, CP Acquisitions LLC (“CP”) and GIC Acquisition, LLC (“GIC”), each of which is controlled by Raymond Chang, Agrify’s Chairman and Chief Executive Officer (the “Debt Purchase Term Sheet”).”

Nature's Miracle Holding Inc. entered into Merger Term Sheet with Agrify Corporation valued at acquisition of Agrify through reverse triangular merger; issuance of shares to Agrify shareholders a (effective 2024-04-17).

“On April 17, 2024, Nature’s Miracle Holding Inc. (the “Company” or “Nature’s Miracle”) entered into a term sheet (the “Merger Term Sheet”) with Agrify Corporation, a Nevada corporation and Nasdaq listed entity (NASDAQ: AGFY) (“Agrify”).”

Permex Petroleum Corp entered into 10% Senior Secured Convertible Debenture valued at $500,000 (effective 2024-04-16).

“Each Unit consists of one 10% Senior Secured Convertible Debenture (a “Debenture”) in the principal amount of US$1,000 and one Common Share Purchase Warrant (a “Warrant”).”

Lexeo Therapeutics, Inc. entered into Third License Agreement with Cornell University valued at $600,000 (effective 2024-04-21).

“On April 21, 2024, Lexeo Therapeutics, Inc. (the “Company”) entered into the Third License Agreement (the “License Agreement”) with Cornell University”

Fintech Ecosystem Development Corp. amended Forward Purchase Agreement with Caltech Trading Corp. valued at $100,000,000 (effective 2024-04-18).

“On April 18, 2024, the Company and Caltech entered into an amendment to the Forward Purchase Agreement (the “Amendment”). The Amendment amends Section 1(a)(i) of the Forward Purchase Agreement regarding share consideration by changing the number and price of shares the Company shall issue and sell to Caltech to 20 million Forward Purchase Shares, for an aggregate purchase price of $100,000,000.”

Global Technology Acquisition Corp. I terminated Sponsor Promissory Note with the Sponsor.

“Pursuant to the Purchase Agreement, the Sponsor Promissory Note was cancelled and extinguished in its entirety, and all amounts owed under the Sponsor Promissory Note was deemed satisfied in full as of the Closing Date.”

Global Technology Acquisition Corp. I amended Amendment with the Insiders and HCG Opportunity.

“Concurrent with the Closing, on the Closing Date, the Company entered into the Amendment with the Insiders and HCG Opportunity.”

Global Technology Acquisition Corp. I entered into Purchase Agreement with HCG Opportunity.

“The foregoing description of the Purchase Agreement is qualified in its entirely by reference to the full text of the Purchase Agreement, a copy of which is filed with this Current Report on Form 8-K as Exhibit 10.1 and is incorporated by reference herein.”

SunPower Inc. amended Second SAFE Amendment with Rodgers Family Freedom and Free Markets Charitable Trust valued at $3,500,000 (effective 2024-04-21).

“On April 21, 2024, the Company entered into an amendment to a simple agreement for future equity, dated February 9, 2024, (the “Second SAFE Amendment” and together with the First SAFE Amendment, the “SAFE Amendments”) with Rodgers Family Freedom and Free Markets Charitable Trust in connection with the Purchaser investing $3,500,000 in the Company.”

SunPower Inc. amended First SAFE Amendment with Rodgers Massey Freedom and Free Markets Charitable Trust valued at $1,500,000 (effective 2024-04-21).

“On April 21, 2024, Complete Solaria, Inc. (the “Company”) entered into an amendment to a simple agreement for future equity, dated January 31, 2024, (the “First SAFE Amendment”) with the Rodgers Massey Freedom and Free Markets Charitable Trust (the “Purchaser”) in connection with the Purchaser investing $1,500,000 in the Company.”

iLearningEngines, Inc. entered into Loan and Security Agreement (Revolving Loan Agreement) with East West Bank valued at $40,000,000 revolving credit facility, up to $20,000,000 accordion feature (effective 2024-04-17).

“On April 17, 2024 (the “Loan Closing Date”), Legacy iLearningEngines entered into a Loan and Security Agreement (the “Revolving Loan Agreement”), by and among Legacy iLearningEngines as borrower (“Borrower”), the lenders party thereto (the “Lenders”) and East West Bank, as administrative agent and collateral agent for the Lenders (“Agent”).”

loanDepot, Inc. amended Amendment No. 4 with UBS AG valued at $225,000,000 (effective 2024-04-16).

“On April 16, 2024, loanDepot.com, LLC (the “Company”), a Delaware limited liability company and an indirect subsidiary of loanDepot, Inc., as seller, entered into Amendment No. 4 (“Amendment No. 4”) to the Amended and Restated Master Repurchase Agreement, dated as of August 11, 2021 (as amended, restated, supplemented or otherwise modified from time to time, the “MRA”) with UBS AG”

Matterport, Inc./DE entered into Agreement and Plan of Merger and Reorganization with CoStar Group, Inc. (effective 2024-04-21).

“On April 21, 2024, Matterport, Inc., a Delaware corporation (the “Company” or “Matterport”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with CoStar Group, Inc.”

RYTHM, Inc. entered into Merger Term Sheet with Nature's Miracle Holding Inc. (effective 2024-04-17).

“On April 17, 2024, Agrify Corporation (the “Company”) entered into a term sheet (the “Merger Term Sheet”) with Nature’s Miracle Holding Inc., a Delaware corporation and Nasdaq listed entity (NASDAQ: NMHI) (“Nature’s Miracle”).”

Danimer Scientific, Inc. entered into Credit Agreement with ABL OPCO LLC (d/b/a Mountain Ridge Capital) valued at $20,000,000 (effective 2024-04-19).

“On April 19, 2024, Danimer Scientific, Inc., Meredian Holdings Group, Inc., Danimer Scientific Holdings, LLC, Meredian, Inc., Danimer Scientific, L.L.C., Danimer Bioplastics, Inc., and Danimer Scientific Kentucky, Inc., (collectively, the “Borrowers”) and the other loan parties party thereto from time to time, entered into an asset-based Credit and Security Agreement (the “Credit Agreement”) with the financial institutions party thereto from time to time (the “Lenders”) and ABL OPCO LLC (d/b/a Mountain Ridge Capital) in its capacity as administrative agent for the Lenders (together with its successors and assigns in such capacity, the “Administrative Agent”).”

Fisker Inc./DE entered into Forbearance Agreement with the Investor (effective 2024-04-21).

“(the “Company”) entered into a Securities Purchase Agreement (as amended, modified, and waived from time to time, the “Securities Purchase Agreement”) with an institutional investor (the “Investor”) pursuant to which the Company agreed to sell, and the Investor agreed to purchase, 0% senior convertible notes due 2025 (the “Series A-1 Notes”) in a registered direct offering.”

Inmune Bio, Inc. entered into Placement Agency Agreement with LifeSci Capital LLC valued at Cash fee equal to 4% of gross proceeds from sale of shares and warrants (effective 2024-04-19).

“Pursuant to a placement agency agreement (the “Placement Agency Agreement”) dated as of April 19, 2024, between the Company and LifeSci Capital LLC (the “Placement Agent Agreement,” the Company engaged the Placement Agent to act as the Company’s sole placement agent in connection with the registered direct offering.”

Inmune Bio, Inc. entered into Securities Purchase Agreement with Purchasers valued at 571,592 shares of common stock and warrants to purchase 571,592 shares at $8.32 per share and warran (effective 2024-04-19).

“On April 19, 2024, INmune Bio, Inc. (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers set forth on the signature page thereto (the “Purchasers”) for the purchase and sale of an aggregate of 571,592 shares of the Company’s common stock (the “Shares”) and common stock warrants to purchase 571,592 shares of its common stock (“Warrants”) in a registered direct offering.”

Sezzle Inc. entered into Credit Agreement with Bastion Funding VI LP, as administrative agent, and certain lenders valued at $150.0 million (effective 2024-04-19).

“On April 19, 2024, Sezzle Funding SPE II, LLC (the Borrower), a wholly owned indirect subsidiary of Sezzle Inc. (the Company), entered into a senior secured asset-based revolving credit facility (the new revolving credit facility), with a borrowing capacity of up to $150.0 million, which is governed by a Revolving Credit and Security Agreement (the Credit Agreement) entered into by the Borrower, certain lenders party thereto and Bastion Funding VI LP, as administrative agent (the Agent).”

HERTZ GLOBAL HOLDINGS, INC amended Amendments with affiliates of THC valued at €1.20 billion (effective 2024-04-16).

“On April 16, 2024, affiliates of THC entered into amendments to the securitization platform for financing activities relating to such affiliates' vehicle fleets in France, the Netherlands, Germany, Spain, and Italy (the “European ABS”) to (i) in the ordinary course, increase the aggregate maximum borrowings thereunder from €1.20 billion to €1.468 billion until November 31, 2024, and (ii) increase the core facility to €1.289 billon from December 1, 2024 through the maturity of the European ABS facility (the “Amendments”).”

HERTZ GLOBAL HOLDINGS, INC amended Amendment No. 1 to Second Amended and Restated Series 2021-A Supplement with Deutsche Bank AG, New York Branch, The Bank of New York Mellon Trust Company, N.A. (effective 2024-04-16).

“On April 16, 2024, Hertz Vehicle Financing III LLC (“HVF III”), a wholly-owned, special-purpose and bankruptcy remote subsidiary of THC, and THC entered into Amendment No. 1 to Second Amended and Restated Series 2021-A Supplement (“Amendment No. 1 to Second A&R Series 2021-A Supplement”) by and among HVF III, as issuer, THC, as administrator, Deutsche Bank AG, New York Branch, as program agent and The Bank of New York Mellon Trust Company, N.A., as trustee.”